Literature DB >> 16154862

High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant.

Akiyoshi Takami, Kanako Mochizuki, Hidesaku Asakura, Hirohito Yamazaki, Hirokazu Okumura, Shinji Nakao.   

Abstract

This retrospective analysis of cytomegalovirus (CMV)-seropositive adult transplant recipients showed that CMV antigenemia occurred after transplantation in 10/10 (100%) recipients of unrelated cord blood, 17/39 (43%) recipients of a related matched donor graft, 16/23 (79%) recipients of an unrelated matched donor graft, and 8/12 (67%) recipients of a mismatched related donor graft. These results suggest that unrelated cord blood transplantation itself may be correlated with a high incidence of CMV reactivation.

Entities:  

Mesh：

Year:  2005        PMID： 16154862

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  16 in total

1.  Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patients.

Authors:  Eun Sang Yi; Yae-Jean Kim
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

2.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

3.  Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients.

Authors:  Filippo Milano; Steven A Pergam; Hu Xie; Wendy M Leisenring; Jonathan A Gutman; Ivy Riffkin; Victor Chow; Michael J Boeckh; Colleen Delaney
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

4.  Cytomegalovirus in hematopoietic stem cell transplant recipients.

Authors:  Per Ljungman; Morgan Hakki; Michael Boeckh
Journal:  Hematol Oncol Clin North Am       Date:  2011-02       Impact factor: 3.722

5.  A Modified Intensive Strategy to Prevent Cytomegalovirus Disease in Seropositive Umbilical Cord Blood Transplantation Recipients.

Authors:  Joshua Aiden Hill; Steven A Pergam; Emily Cox; Hu Xie; Wendy M Leisenring; Michael Boeckh; Colleen Delaney; Filippo Milano
Journal:  Biol Blood Marrow Transplant       Date:  2018-05-16       Impact factor: 5.742

6.  Cytomegalovirus ventriculoencephalitis after unrelated double cord blood stem cell transplantation with an alemtuzumab-containing preparative regimen for Philadelphia-positive acute lymphoblastic leukemia.

Authors:  Seok Lee; Si-Hyun Kim; Su-Mi Choi; Dong-Gun Lee; Sung-Yong Kim; Jong-Wook Lee; Woo-Sung Min; Wan-Shik Shin; Chun-Choo Kim
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

7.  Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.

Authors:  Jill C Beck; John E Wagner; Todd E DeFor; Claudio G Brunstein; Mark R Schleiss; Jo-Anne Young; Daniel H Weisdorf; Sarah Cooley; Jeffrey S Miller; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-26       Impact factor: 5.742

8.  Risk of cytomegalovirus infection and disease after umbilical cord blood transplantation in children.

Authors:  Pierre Alex Crisinel; Michel Duval; Delphine Thuillard Crisinel; Brigitte Mallette; Nathalie Bellier; Marie-France Vachon; Laurence Dedeken; Céline Rousseau; Bruce Tapiero; Philippe Ovetchkine
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

9.  The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches.

Authors:  Natasha A Jain; Kit Lu; Sawa Ito; Pawel Muranski; Christopher S Hourigan; Janice Haggerty; Puja D Chokshi; Catalina Ramos; Elena Cho; Lisa Cook; Richard Childs; Minoo Battiwalla; A John Barrett
Journal:  Cytotherapy       Date:  2014-05-13       Impact factor: 5.414

10.  Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants.

Authors:  Eun Sang Yi; Ji Won Lee; Yae-Jean Kim; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Ann Hematol       Date:  2021-11-02       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.